Marianne Carroll, DO
Dermatology · Lake Worth, FLNPI 1851599088
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.4%), consulting fees and education — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Medimetriks Pharmaceuticals, Inc. at 42.3% of the total.
Across 172 payments — averaging $43.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medimetriks Pharmaceuticals, Inc.$3K
- Pfizer$626
- Merz North America, Inc.$516
- Sun Pharmaceutical Industries Inc.$372
- VYNE Pharmaceuticals Inc.$361
- Revance Therapeutics, Inc.$328
- plus $2K from 22 others
What the payments were for
- Consulting fees$3,15042%
- Food & beverage$4,20856%
- Education$1071%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medimetriks Pharmaceuticals, Inc. | 10 | $3,160 |
| Pfizer | 26 | $626 |
| Merz North America, Inc. | 16 | $516 |
| Sun Pharmaceutical Industries Inc. | 9 | $372 |
| VYNE Pharmaceuticals Inc. | 24 | $361 |
| Revance Therapeutics, Inc. | 3 | $328 |
| AbbVie | 10 | $254 |
| LEO Pharma Inc. | 10 | $250 |
| Galderma Laboratories, L.p. | 6 | $233 |
| Dermavant Sciences, Inc. | 10 | $231 |
| Incyte Corporation | 4 | $159 |
| Amgen | 6 | $154 |
| Organogenesis Inc. | 6 | $134 |
| Almirall LLC | 5 | $121 |
| Novartis | 5 | $118 |
| Biofrontera Inc. | 9 | $95 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $92 |
| Jazz Pharmaceuticals Inc. | 1 | $35 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $34 |
| Lilly USA, LLC | 1 | $28 |
| UCB, Inc. | 1 | $27 |
| Dermira, Inc. | 1 | $27 |
| Strata Skin Sciences, Inc. | 2 | $26 |
| Johnson & Johnson | 1 | $22 |
| Botanix SB Inc | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| Mimedx Group, Inc. | 1 | $18 |
| Organon | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Neo-Synalar$2,450
- Tovet (emollient formulation)$1,050
- Genadur$1,050
- Clindacin P$350
- DAXI$140
- XEOMIN$128
- EPIDUO FORTE$120
- ORACEA$120
- SOOLANTRA$120
- ILUMYA$119
- ADBRY$116
- CIBINQO$114
- VTAMA$110
How this compares
$7,464 in reported general payments places this provider in the 70th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 42 | $3,025 |
| Cephalexin | 44 | $289 |
| Triamcinolone Acetonide | 24 | $248 |
| Mupirocin | 27 | $193 |
| Ketoconazole | 15 | $162 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Lake Worth
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.